1. Search Result
Search Result
Results for "

MTX

" in MedChemExpress (MCE) Product Catalog:

29

Inhibitors & Agonists

1

Fluorescent Dye

2

Peptides

7

Natural
Products

2

Isotope-Labeled Compounds

1

Antibodies

5

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-107364
    MTX-211
    3 Publications Verification

    Mol 211

    EGFR PI3K Cancer
    MTX-211 (Mol 211) is a dual inhibitor of EGFR and PI3K with IC50 values of <100 nM. MTX-211 can be used for the research of cancer and other diseases .
    MTX-211
  • HY-148771

    PROTAC AR-V7 degrader-2

    PROTACs Androgen Receptor Apoptosis Cancer
    MTX-23 is an AR-based PROTAC. MTX-23 inhibits CaP cellular proliferation by degrading AR-V7 and AR-FL. MTX-23 induces apoptosis .
    MTX-23
  • HY-160019

    Deubiquitinase Mitophagy Neurological Disease
    MTX115325 (Example 1) is an orally active, brain-penetrating USP30 inhibitor (IC50=12 nM) with neuroprotective activity. MTX115325 increases ubiquitination (EC50=32 nM) of the mitochondrial outer membrane protein TOM20 (a USP30 substrate), increasing mitophagy. MTX115325 prevents dopaminergic neuron loss and preserves striatal dopamine .
    MTX115325
  • HY-162713

    EGFR PI3K PPAR Cancer
    MTX-531 is an oral drug that inhibits EGFR (with an IC50 of 14.7 nM) and PI3K (with IC50 values of 6.4, 233, 8.3, and 1.1 nM for PI3Kα, PI3Kβ, PI3Kγ, and PI3Kδ respectively), and it has anti-tumor effects. MTX-531 also acts as a weak agonist of PPARγ, with an IC50 of 2.5 µM, helping to alleviate hyperglycemia induced by PI3K inhibitors .
    MTX-531
  • HY-RS22244

    Small Interfering RNA (siRNA) Others

    Mtx1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mtx1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

    Mtx1 Mouse Pre-designed siRNA Set A
    Mtx1 Mouse Pre-designed siRNA Set A
  • HY-RS08828

    Small Interfering RNA (siRNA) Others

    MTX1 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MTX1 Human Pre-designed siRNA Set A
    MTX1 Human Pre-designed siRNA Set A
  • HY-156872

    PI3K EGFR Syk Apoptosis Cancer
    MTX-216 is a dual ATP-competitive inhibitor of PI3K and EGFR. MTX-216 cosuppresses Ki-67 and ribosomal S6 phosphorylation and induces apoptosis in NF1 LOF cells. MTX-216 suppresses the activity of SYK kinase, with an IC50 of 281 nM. MTX-216 is used in the research of Melanoma .
    MTX-216
  • HY-149556

    EGFR PI3K Cancer
    MTX-241F is a selective small molecule inhibitor targeting EGFR and PI3 kinase family members. MTX-241F is able to penetrate the blood-brain barrier and control tumor growth over the long term. MTX-241F exhibits radiosensitizing activity in patient-derived DIPG neurospheres and may be used in the study of diffuse intrinsic pontine glioma (DIPG) .
    MTX-241F
  • HY-RS08829

    Small Interfering RNA (siRNA) Others

    MTX2 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MTX2 Human Pre-designed siRNA Set A
    MTX2 Human Pre-designed siRNA Set A
  • HY-RS28766

    Small Interfering RNA (siRNA) Others
    Mtx1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Mtx1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.
    Mtx1 Rat Pre-designed siRNA Set A
    Mtx1 Rat Pre-designed siRNA Set A
  • HY-RS08830

    Small Interfering RNA (siRNA) Others

    MTX3 Human Pre-designed siRNA Set A contains three designed siRNAs for MTX3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

    MTX3 Human Pre-designed siRNA Set A
    MTX3 Human Pre-designed siRNA Set A
  • HY-D2435

    Fluorescent Dye Inflammation/Immunology Cancer
    CDDP-PEG-Cy3 is a MTX-PEG conjugate labeled with Cy3 (HY-D0822). The Cy3 fluorophore is commonly used in applications such as immunolabeling, nucleic acid labeling, fluorescence microscopy, and flow cytometry. The maximum emission wavelength of Cy3 is approximately 562-570 nm. Methotrexate (Amethopterin; MTX) (HY-14519), an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis. Methotrexate, also an immunosuppressant and antineoplastic agent, is used for the research of rheumatoid arthritis and a number of different cancers (such as acute lymphoblastic leukemia) .
    MTX-PEG-Cy3
  • HY-169067

    MTX-C

    p38 MAPK Cancer
    0-Methoxy-canthin-6-one (Mtx-C) is a DNA damage inducer. 0-Methoxy-canthin-6-one promotes cell cycle arrest at the G2/M phase by intercalating into DNA, thereby inducing myeloid differentiation of acute myeloid leukemia (AML) cells and leukemic stem cells (LSCs). The myeloid differentiation in AML and LSC cells is characterized by increased expression of myeloperoxidase, CD15, CD11b, and CD14, as well as activation of p38 MAPK. 0-Methoxy-canthin-6-one can be used in leukemia research .
    10-Methoxy-canthin-6-one
  • HY-17556A

    Leucovorin disodium

    Endogenous Metabolite Antifolate Cancer
    Folinic acid (Leucovorin) disodium is a biological folic acid and is a forms of vitamin B9. Folinic acid disodium is generally administered along with Methotrexate (HY-14519) as a rescue agent to decrease MTX-induced toxicity. Folinic acid disodium and Sfluorouracil adjuvant chemotherapy shows effective in colon carcinoma .
    Folinic acid disodium
  • HY-130569

    Drug Metabolite Inflammation/Immunology Cancer
    7-Hydroxymethotrexate is a major metabolite of Methotrexate (MTX; HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
    7-Hydroxymethotrexate
  • HY-13617

    CGP 30694

    Antifolate Cancer
    Edatrexate (CGP 30694), as known as 10-Ethyl-10-deazaaminopterin, is Methotrexate (HY-14519) analog, exhibits antitumor activity against MTX-resistant tumors. Edatrexate is an antifolate antimetabolite, can be used for reasearch of non-small-cell lung cancer, breast cancer, non-Hodgkin's lymphoma, and cancer of the head and neck .
    Edatrexate
  • HY-13664
    Folinic acid calcium
    Maximum Cited Publications
    11 Publications Verification

    Leucovorin calcium; Calcium folinate

    Antifolate Endogenous Metabolite Cancer
    Folinic acid calcium (Leucovorin calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity .
    Folinic acid calcium
  • HY-B0080
    Folinic acid calcium salt pentahydrate
    Maximum Cited Publications
    11 Publications Verification

    Leucovorin calcium salt pentahydrate

    Antifolate Endogenous Metabolite Cancer
    Folinic acid calcium salt pentahydrate (Leucovorin calcium salt pentahydrate) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity .
    Folinic acid calcium salt pentahydrate
  • HY-115429

    6R-Leucovorin calcium; (6R)-Folinic acid calcium

    Drug Isomer Metabolic Disease
    Calcium dextrofolinate is a stereoisomer of Calcium folinate. Calcium folinate (Folinic acid calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity .
    Calcium dextrofolinate
  • HY-13664R

    Leucovorin calcium (Standard); Calcium folinate (Standard)

    Reference Standards Antifolate Endogenous Metabolite Cancer
    Folinic acid (calcium) (Standard) is the analytical standard of Folinic acid (calcium). This product is intended for research and analytical applications. Folinic acid calcium (Leucovorin calcium) is a biological folic acid and is generally administered along with methotrexate (MTX) as a rescue agent to decrease MTX-induced toxicity .
    Folinic acid calcium (Standard)
  • HY-W653912A

    Isotope-Labeled Compounds Cancer
    Leucovorin-d4 (Leucovorin-d4) calcium hydrate, >90% is a deuterated labeled Folinic acid (Leucovorin, HY-17556). Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (MTX) (HY-14519) as a rescue agent to decrease MTX-induced toxicity .
    Leucovorin-d4 (calcium hydrate), >90%
  • HY-17556
    Folinic acid
    Maximum Cited Publications
    11 Publications Verification

    leucovorin

    Antifolate Endogenous Metabolite Cancer
    Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (HY-14519) as a rescue agent to decrease MTX-induced toxicity .
    Folinic acid
  • HY-N0913

    Endogenous Metabolite Others
    Manninotriose is a novel and important player in the RFO(Raffinose family oligosaccharides) metabolism of red dead deadnettle; potential to improve the side effects of MTX for ALL treatment.
    Manninotriose
  • HY-W047788

    Amino Acid Derivatives Others
    H-Dab(Boc)-OH is an amino acid derivative with a Boc protecting group, which can be used to synthesize methotrexate (MTX) analogs with antitumor and antifolate activities .
    H-Dab(Boc)-OH
  • HY-121702

    Drug Derivative Cancer
    Dihydrohomofolic acid, an analog of dihydrofolic acid (H2F), might be effective against tumor in which resistance to methotrexate (MTX) is associated with high leveIs of H2F-reductase .
    Dihydrohomofolic acid
  • HY-17556R

    leucovorin (Standard)

    Reference Standards Antifolate Endogenous Metabolite Cancer
    Folinic acid (Standard) is the analytical standard of Folinic acid. This product is intended for research and analytical applications. Folinic acid (Leucovorin) is a biological folic acid and is generally administered along with Methotrexate (HY-14519) as a rescue agent to decrease MTX-induced toxicity .
    Folinic acid (Standard)
  • HY-W654227

    Isotope-Labeled Compounds Drug Metabolite Inflammation/Immunology
    7-Hydroxy methotrexate-d3 (ammonium salt) is deuterium labeled 7-Hydroxymethotrexate. 7-Hydroxymethotrexate is a major metabolite of Methotrexate (MTX; HY-14519). Methotrexate, an antimetabolite and antifolate agent, inhibits the enzyme dihydrofolate reductase, thereby preventing the conversion of folic acid into tetrahydrofolate, and inhibiting DNA synthesis .
    7-Hydroxy methotrexate-d3 ammonium salt
  • HY-P11101

    Biochemical Assay Reagents Others
    plCSA-BP is a Placental CSA-binding peptide. plCSA-BP binds specifically to trophoblasts and not to other cell types in the placenta or to CSA-expressing cells in other tissues. plCSA-BP can guide nanoparticles for the targeted delivery of payloads (such as Indocyanine green (ICG) (HY-D0711) and Methotrexate (MTX) (HY-14519)) to the placenta, promising for placenta-specific drug delivery .
    plCSA-BP
  • HY-124093

    Thymidylate Synthase Bacterial Infection Cancer
    8-Deazahomofolic acid is an inhibitor of thymidylate synthase (TS) and other folate-related enzymes. 8-Deazahomofolic acid shows inhibitory activity against folate-dependent S. faecium, L. casei, and MTX (HY-14519) resistant strains. 8-Deazahomofolic acid also inhibits the growth of L1210 leukemia cells, with an IC50 value of 87.5 μM. 8-Deazahomofolic acid can be used in research on bacterial infections and tumors .
    8-Deazahomofolic acid

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: